Astrocyte-Derived Pentraxin 3 Supports Blood–Brain Barrier Integrity Under Acute Phase of Stroke
Author(s) -
Akihiro Shindo,
Takakuni Maki,
Emiri T. Mandeville,
Anna C. Liang,
Naohiro Egawa,
Kanako Itoh,
Naoki Itoh,
Mia C. Borlongan,
Julie C. Holder,
Tsu Tshen Chuang,
John D. McNeish,
Hidekazu Tomimoto,
Josephine Lok,
Eng H. Lo,
Ken Arai
Publication year - 2016
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.115.012133
Subject(s) - astrocyte , medicine , blood–brain barrier , ptx3 , vascular permeability , vascular endothelial growth factor , endothelial stem cell , brain ischemia , endothelium , inflammation , ischemia , pathology , microbiology and biotechnology , immunology , in vitro , biology , central nervous system , biochemistry , vegf receptors
Pentraxin 3 (PTX3) is released on inflammatory responses in many organs. However, roles of PTX3 in brain are still mostly unknown. Here we asked whether and how PTX3 contributes to blood-brain barrier dysfunction during the acute phase of ischemic stroke.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom